MedTrace Logo

DPC in Primary Molars.

NCT05222243 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-02-03

No results posted yet for this study

Summary

To evaluate clinical and radiographical outcomes of direct pulp capping using calcium hydroxide (CH), mineral trioxide aggregate (MTA), and premedicated direct pulp capping (PDPC) with formocresol (FC) in primary teeth.

Conditions

  • Direct Pulp Capping in Primary Teeth

Interventions

DRUG

Direct pulp capping with calcium hydroxide

Capping exposed dental pulps during cavity preparation in primary teeth with calcium hydroxide

DRUG

Direct pulp capping with MTA

Capping exposed dental pulps during cavity preparation in primary teeth with MTA

DRUG

Direct pulp capping with Formocresol

Capping exposed dental pulps during cavity preparation in primary teeth with zinc oxide eugenol after medication with formocresol

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-08-03
Completion
2020-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05222243 on ClinicalTrials.gov